Plotted Points Statistics |
2,4-D |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 20 | 101% | 36% | 93% | 33% |
>= Reporting Level | 262 | 107% | 37% | 102% | 28% |
Total | 282 | 107% | 37% | 101% | 29% |
Sample Statistics |
2,4-D |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 282 | 98% | Spiked |
Estimated Values | 44 | 15% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 2 | 1% | Spiked |
Spiked | 287 | . | |
False Negatives | 3 | 1% | 3 out of 287 |
Not Spiked | 148 | . | |
False Positives | 8 | 5% | 8 out of 148 |
Plotted Points Statistics |
2,4-DB |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 168 | 70% | 20% | 67% | 11% |
Total | 168 | 70% | 20% | 67% | 11% |
Sample Statistics |
2,4-DB |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 168 | 100% | Spiked |
Estimated Values | 53 | 32% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 168 | . | |
False Negatives | 0 | 0% | 0 out of 168 |
Not Spiked | 267 | . | |
False Positives | 8 | 3% | 8 out of 267 |
BQS OBSP Determination: |
2,4-D + 2,4-D METHYL ESTER (SUM) |
METHOD: 2060 , TESTIDCODE: 66496CAL13 |
Open Data Set |
Plotted Points Statistics |
2,4-D + 2,4-D METHYL ESTER (SUM) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 89 | 86% | 20% | 86% | 9% |
Total | 89 | 86% | 20% | 86% | 9% |
Sample Statistics |
2,4-D + 2,4-D METHYL ESTER (SUM) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 89 | 99% | Spiked |
Estimated Values | 49 | 54% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 90 | . | |
False Negatives | 1 | 1% | 1 out of 90 |
Not Spiked | 89 | . | |
False Positives | 1 | 1% | 1 out of 89 |
Plotted Points Statistics |
2,4-D METHYL ESTER |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 33 | 86% | 19% | 84% | 14% |
>= Reporting Level | 155 | 74% | 31% | 77% | 25% |
Total | 188 | 76% | 30% | 80% | 22% |
Sample Statistics |
2,4-D METHYL ESTER |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 188 | 84% | Spiked |
Estimated Values | 98 | 44% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 9 | 4% | Spiked |
Spiked | 223 | . | |
False Negatives | 26 | 12% | 26 out of 223 |
Not Spiked | 205 | . | |
False Positives | 37 | 18% | 37 out of 205 |
BQS OBSP Determination: |
3(4-CHLOROPHENYL) METHYL UREA |
METHOD: 2060 , TESTIDCODE: 61692LCM29 |
Open Data Set |
Plotted Points Statistics |
3(4-CHLOROPHENYL) METHYL UREA |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 25 | 87% | 32% | 83% | 17% |
>= Reporting Level | 144 | 110% | 31% | 105% | 18% |
Total | 169 | 106% | 32% | 103% | 21% |
Sample Statistics |
3(4-CHLOROPHENYL) METHYL UREA |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 169 | 99% | Spiked |
Estimated Values | 40 | 24% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 170 | . | |
False Negatives | 1 | 1% | 1 out of 170 |
Not Spiked | 265 | . | |
False Positives | 0 | 0% | 0 out of 265 |
Plotted Points Statistics |
3-HYDROXYCARBOFURAN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 6 | 117% | 7% | 117% | 8% |
>= Reporting Level | 161 | 101% | 33% | 105% | 23% |
Total | 167 | 101% | 32% | 107% | 23% |
Sample Statistics |
3-HYDROXYCARBOFURAN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 167 | 99% | Spiked |
Estimated Values | 35 | 21% | Spiked |
Deleted Values | 3 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 169 | . | |
False Negatives | 1 | 1% | 1 out of 168 |
Not Spiked | 266 | . | |
False Positives | 1 | 0% | 1 out of 264 |
Plotted Points Statistics |
3-KETOCARBOFURAN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 13 | 65% | 42% | 66% | 24% |
>= Reporting Level | 3 | 35% | 30% | 44% | 43% |
Total | 16 | 59% | 41% | 59% | 30% |
Sample Statistics |
3-KETOCARBOFURAN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 16 | 38% | Spiked |
Estimated Values | 16 | 38% | Spiked |
Deleted Values | 5 | 3% | Spiked + Not Spiked |
Spiked, Censored | 15 | 36% | Spiked |
Spiked | 44 | . | |
False Negatives | 11 | 26% | 11 out of 42 |
Not Spiked | 119 | . | |
False Positives | 0 | 0% | 0 out of 116 |
Plotted Points Statistics |
ACIFLUORFEN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 12 | 66% | 24% | 62% | 22% |
>= Reporting Level | 166 | 73% | 34% | 69% | 35% |
Total | 178 | 73% | 34% | 67% | 35% |
Sample Statistics |
ACIFLUORFEN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 178 | 99% | Spiked |
Estimated Values | 71 | 40% | Spiked |
Deleted Values | 2 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 180 | . | |
False Negatives | 1 | 1% | 1 out of 179 |
Not Spiked | 255 | . | |
False Positives | 0 | 0% | 0 out of 254 |
Plotted Points Statistics |
ALDICARB |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 42% | 12% | 46% | 8% |
>= Reporting Level | 137 | 58% | 25% | 59% | 20% |
Total | 142 | 57% | 25% | 58% | 21% |
Sample Statistics |
ALDICARB |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 142 | 78% | Spiked |
Estimated Values | 134 | 74% | Spiked |
Deleted Values | 2 | 0% | Spiked + Not Spiked |
Spiked, Censored | 22 | 12% | Spiked |
Spiked | 182 | . | |
False Negatives | 18 | 10% | 18 out of 182 |
Not Spiked | 253 | . | |
False Positives | 1 | 0% | 1 out of 251 |
Plotted Points Statistics |
ALDICARB SULFONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 16 | 95% | 20% | 91% | 8% |
>= Reporting Level | 191 | 82% | 26% | 85% | 24% |
Total | 207 | 83% | 26% | 85% | 22% |
Sample Statistics |
ALDICARB SULFONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 207 | 98% | Spiked |
Estimated Values | 99 | 47% | Spiked |
Deleted Values | 3 | 1% | Spiked + Not Spiked |
Spiked, Censored | 4 | 2% | Spiked |
Spiked | 213 | . | |
False Negatives | 1 | 0% | 1 out of 212 |
Not Spiked | 222 | . | |
False Positives | 26 | 12% | 26 out of 220 |
Plotted Points Statistics |
ALDICARB SULFOXIDE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 26 | 111% | 26% | 112% | 27% |
>= Reporting Level | 182 | 77% | 39% | 77% | 40% |
Total | 208 | 81% | 39% | 81% | 41% |
Sample Statistics |
ALDICARB SULFOXIDE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 208 | 92% | Spiked |
Estimated Values | 175 | 78% | Spiked |
Deleted Values | 3 | 1% | Spiked + Not Spiked |
Spiked, Censored | 3 | 1% | Spiked |
Spiked | 226 | . | |
False Negatives | 14 | 6% | 14 out of 225 |
Not Spiked | 200 | . | |
False Positives | 16 | 8% | 16 out of 198 |
Plotted Points Statistics |
ATRAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 94% | 6% | 93% | 7% |
>= Reporting Level | 240 | 104% | 27% | 106% | 23% |
Total | 244 | 104% | 27% | 105% | 23% |
Sample Statistics |
ATRAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 244 | 100% | Spiked |
Estimated Values | 33 | 14% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 244 | . | |
False Negatives | 0 | 0% | 0 out of 244 |
Not Spiked | 191 | . | |
False Positives | 1 | 1% | 1 out of 191 |
Plotted Points Statistics |
BENDIOCARB |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 7 | 78% | 21% | 77% | 12% |
>= Reporting Level | 148 | 88% | 39% | 92% | 21% |
Total | 155 | 87% | 38% | 92% | 21% |
Sample Statistics |
BENDIOCARB |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 155 | 89% | Spiked |
Estimated Values | 83 | 48% | Spiked |
Deleted Values | 3 | 1% | Spiked + Not Spiked |
Spiked, Censored | 3 | 2% | Spiked |
Spiked | 175 | . | |
False Negatives | 16 | 9% | 16 out of 174 |
Not Spiked | 260 | . | |
False Positives | 4 | 2% | 4 out of 258 |
Plotted Points Statistics |
BENOMYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 214 | 106% | 52% | 109% | 40% |
Total | 214 | 106% | 52% | 109% | 40% |
Sample Statistics |
BENOMYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 214 | 99% | Spiked |
Estimated Values | 102 | 47% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 216 | . | |
False Negatives | 2 | 1% | 2 out of 216 |
Not Spiked | 219 | . | |
False Positives | 0 | 0% | 0 out of 219 |
Plotted Points Statistics |
BENSULFURON-METHYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 7 | 80% | 30% | 63% | 29% |
>= Reporting Level | 156 | 96% | 55% | 97% | 56% |
Total | 163 | 96% | 54% | 96% | 55% |
Sample Statistics |
BENSULFURON-METHYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 163 | 99% | Spiked |
Estimated Values | 67 | 41% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 1% | Spiked |
Spiked | 165 | . | |
False Negatives | 1 | 1% | 1 out of 165 |
Not Spiked | 261 | . | |
False Positives | 0 | 0% | 0 out of 261 |
Plotted Points Statistics |
BENTAZONE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 78% | 10% | 79% | 12% |
>= Reporting Level | 219 | 68% | 24% | 70% | 19% |
Total | 223 | 68% | 24% | 71% | 19% |
Sample Statistics |
BENTAZONE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 223 | 87% | Spiked |
Estimated Values | 111 | 43% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 256 | . | |
False Negatives | 33 | 13% | 33 out of 256 |
Not Spiked | 179 | . | |
False Positives | 2 | 1% | 2 out of 179 |
Plotted Points Statistics |
BROMACIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 23 | 104% | 30% | 107% | 22% |
>= Reporting Level | 247 | 99% | 36% | 107% | 22% |
Total | 270 | 100% | 35% | 107% | 22% |
Sample Statistics |
BROMACIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 270 | 98% | Spiked |
Estimated Values | 131 | 48% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 0% | Spiked |
Spiked | 275 | . | |
False Negatives | 4 | 1% | 4 out of 275 |
Not Spiked | 160 | . | |
False Positives | 0 | 0% | 0 out of 160 |
Plotted Points Statistics |
BROMOXYNIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 51% | 11% | 49% | 11% |
>= Reporting Level | 169 | 55% | 28% | 52% | 29% |
Total | 173 | 55% | 28% | 52% | 28% |
Sample Statistics |
BROMOXYNIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 173 | 97% | Spiked |
Estimated Values | 147 | 83% | Spiked |
Deleted Values | 1 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 1% | Spiked |
Spiked | 179 | . | |
False Negatives | 4 | 2% | 4 out of 178 |
Not Spiked | 256 | . | |
False Positives | 1 | 0% | 1 out of 256 |
Plotted Points Statistics |
CAFFEINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 11 | 96% | 23% | 92% | 22% |
>= Reporting Level | 224 | 116% | 30% | 115% | 25% |
Total | 235 | 115% | 30% | 114% | 26% |
Sample Statistics |
CAFFEINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 235 | 99% | Spiked |
Estimated Values | 42 | 18% | Spiked |
Deleted Values | 4 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 0% | Spiked |
Spiked | 241 | . | |
False Negatives | 1 | 0% | 1 out of 237 |
Not Spiked | 194 | . | |
False Positives | 2 | 1% | 2 out of 194 |
Plotted Points Statistics |
CARBARYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 8 | 77% | 35% | 86% | 39% |
>= Reporting Level | 228 | 88% | 28% | 96% | 22% |
Total | 236 | 88% | 29% | 96% | 23% |
Sample Statistics |
CARBARYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 236 | 99% | Spiked |
Estimated Values | 47 | 20% | Spiked |
Deleted Values | 3 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 240 | . | |
False Negatives | 3 | 1% | 3 out of 239 |
Not Spiked | 195 | . | |
False Positives | 0 | 0% | 0 out of 193 |
Plotted Points Statistics |
CARBOFURAN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 76% | 14% | 76% | 15% |
>= Reporting Level | 196 | 97% | 19% | 99% | 17% |
Total | 198 | 96% | 19% | 99% | 17% |
Sample Statistics |
CARBOFURAN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 198 | 100% | Spiked |
Estimated Values | 12 | 6% | Spiked |
Deleted Values | 3 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 199 | . | |
False Negatives | 0 | 0% | 0 out of 198 |
Not Spiked | 236 | . | |
False Positives | 0 | 0% | 0 out of 234 |
BQS OBSP Determination: |
CHLORAMBEN, METHYL ESTER |
METHOD: 2060 , TESTIDCODE: 61188LCM29 |
Open Data Set |
Plotted Points Statistics |
CHLORAMBEN, METHYL ESTER |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 10 | 120% | 21% | 119% | 26% |
>= Reporting Level | 127 | 90% | 31% | 93% | 24% |
Total | 137 | 92% | 32% | 95% | 24% |
Sample Statistics |
CHLORAMBEN, METHYL ESTER |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 137 | 79% | Spiked |
Estimated Values | 50 | 29% | Spiked |
Deleted Values | 2 | 0% | Spiked + Not Spiked |
Spiked, Censored | 7 | 4% | Spiked |
Spiked | 174 | . | |
False Negatives | 30 | 17% | 30 out of 174 |
Not Spiked | 257 | . | |
False Positives | 3 | 1% | 3 out of 255 |
Plotted Points Statistics |
CHLORIMURON ETHYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 8 | 59% | 46% | 55% | 56% |
>= Reporting Level | 173 | 84% | 69% | 80% | 77% |
Total | 181 | 83% | 69% | 79% | 76% |
Sample Statistics |
CHLORIMURON ETHYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 181 | 81% | Spiked |
Estimated Values | 151 | 68% | Spiked |
Deleted Values | 1 | 0% | Spiked + Not Spiked |
Spiked, Censored | 4 | 2% | Spiked |
Spiked | 224 | . | |
False Negatives | 38 | 17% | 38 out of 223 |
Not Spiked | 201 | . | |
False Positives | 0 | 0% | 0 out of 201 |
Plotted Points Statistics |
CHLOROTHALONIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 13 | 19% | 16% | 15% | 10% |
Total | 13 | 19% | 16% | 15% | 10% |
Sample Statistics |
CHLOROTHALONIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 13 | 19% | Spiked |
Estimated Values | 13 | 19% | Spiked |
Deleted Values | 3 | 2% | Spiked + Not Spiked |
Spiked, Censored | 9 | 13% | Spiked |
Spiked | 68 | . | |
False Negatives | 45 | 67% | 45 out of 67 |
Not Spiked | 95 | . | |
False Positives | 0 | 0% | 0 out of 93 |
Plotted Points Statistics |
CLOPYRALID |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 12 | 55% | 15% | 59% | 13% |
>= Reporting Level | 149 | 62% | 23% | 62% | 21% |
Total | 161 | 62% | 23% | 61% | 20% |
Sample Statistics |
CLOPYRALID |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 161 | 94% | Spiked |
Estimated Values | 98 | 57% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 2 | 1% | Spiked |
Spiked | 171 | . | |
False Negatives | 8 | 5% | 8 out of 171 |
Not Spiked | 264 | . | |
False Positives | 0 | 0% | 0 out of 264 |
Plotted Points Statistics |
CYCLOATE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 14 | 71% | 11% | 71% | 15% |
>= Reporting Level | 155 | 71% | 22% | 75% | 16% |
Total | 169 | 71% | 21% | 74% | 16% |
Sample Statistics |
CYCLOATE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 169 | 98% | Spiked |
Estimated Values | 41 | 24% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 173 | . | |
False Negatives | 4 | 2% | 4 out of 173 |
Not Spiked | 262 | . | |
False Positives | 1 | 0% | 1 out of 262 |
Plotted Points Statistics |
DACTHAL MONOACID |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 8 | 120% | 24% | 128% | 28% |
>= Reporting Level | 139 | 88% | 26% | 83% | 25% |
Total | 147 | 90% | 27% | 85% | 28% |
Sample Statistics |
DACTHAL MONOACID |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 147 | 98% | Spiked |
Estimated Values | 20 | 13% | Spiked |
Deleted Values | 1 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 150 | . | |
False Negatives | 3 | 2% | 3 out of 150 |
Not Spiked | 273 | . | |
False Positives | 1 | 0% | 1 out of 272 |
Plotted Points Statistics |
DEETHYLATRAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 21 | 78% | 35% | 82% | 39% |
>= Reporting Level | 209 | 85% | 27% | 88% | 19% |
Total | 230 | 85% | 28% | 88% | 20% |
Sample Statistics |
DEETHYLATRAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 230 | 100% | Spiked |
Estimated Values | 97 | 42% | Spiked |
Deleted Values | 2 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 231 | . | |
False Negatives | 0 | 0% | 0 out of 230 |
Not Spiked | 204 | . | |
False Positives | 0 | 0% | 0 out of 203 |
BQS OBSP Determination: |
DEETHYLDEISOPROPYLATRAZINE |
METHOD: 2060 , TESTIDCODE: 04039LCM29 |
Open Data Set |
Plotted Points Statistics |
DEETHYLDEISOPROPYLATRAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 15 | 39% | 29% | 33% | 31% |
Total | 15 | 39% | 29% | 33% | 31% |
Sample Statistics |
DEETHYLDEISOPROPYLATRAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 15 | 94% | Spiked |
Estimated Values | 15 | 94% | Spiked |
Deleted Values | 1 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 6% | Spiked |
Spiked | 16 | . | |
False Negatives | 0 | 0% | 0 out of 16 |
Not Spiked | 131 | . | |
False Positives | 0 | 0% | 0 out of 130 |
Plotted Points Statistics |
DEISOPROPYLATRAZINE |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 27 | 92% | 32% | 95% | 25% |
>= Reporting Level | 188 | 81% | 26% | 81% | 23% |
Total | 215 | 82% | 27% | 82% | 25% |
Sample Statistics |
DEISOPROPYLATRAZINE |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 215 | 98% | Spiked |
Estimated Values | 106 | 48% | Spiked |
Deleted Values | 2 | 0% | Spiked + Not Spiked |
Spiked, Censored | 3 | 1% | Spiked |
Spiked | 219 | . | |
False Negatives | 1 | 0% | 1 out of 219 |
Not Spiked | 216 | . | |
False Positives | 2 | 1% | 2 out of 214 |
Plotted Points Statistics |
DICAMBA |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 7 | 101% | 19% | 101% | 29% |
>= Reporting Level | 235 | 94% | 28% | 97% | 33% |
Total | 242 | 94% | 28% | 97% | 32% |
Sample Statistics |
DICAMBA |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 242 | 92% | Spiked |
Estimated Values | 24 | 9% | Spiked |
Deleted Values | 2 | 0% | Spiked + Not Spiked |
Spiked, Censored | 3 | 1% | Spiked |
Spiked | 264 | . | |
False Negatives | 17 | 6% | 17 out of 262 |
Not Spiked | 171 | . | |
False Positives | 0 | 0% | 0 out of 171 |
BQS OBSP Determination: |
DICHLOROPROP (DICHLORPROP) |
METHOD: 2060 , TESTIDCODE: 49302LCM29 |
Open Data Set |
Plotted Points Statistics |
DICHLOROPROP (DICHLORPROP) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 191 | 90% | 19% | 89% | 16% |
Total | 191 | 90% | 19% | 89% | 16% |
Sample Statistics |
DICHLOROPROP (DICHLORPROP) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 191 | 99% | Spiked |
Estimated Values | 16 | 8% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 193 | . | |
False Negatives | 2 | 1% | 2 out of 193 |
Not Spiked | 242 | . | |
False Positives | 2 | 1% | 2 out of 242 |
Plotted Points Statistics |
DINOSEB |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 6 | 110% | 14% | 105% | 17% |
>= Reporting Level | 200 | 66% | 29% | 60% | 31% |
Total | 206 | 68% | 29% | 61% | 33% |
Sample Statistics |
DINOSEB |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 206 | 100% | Spiked |
Estimated Values | 34 | 16% | Spiked |
Deleted Values | 1 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 207 | . | |
False Negatives | 1 | 0% | 1 out of 207 |
Not Spiked | 228 | . | |
False Positives | 1 | 0% | 1 out of 227 |
Plotted Points Statistics |
DIPHENAMID |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 8 | 92% | 14% | 93% | 10% |
>= Reporting Level | 153 | 101% | 14% | 103% | 9% |
Total | 161 | 101% | 14% | 102% | 10% |
Sample Statistics |
DIPHENAMID |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 161 | 100% | Spiked |
Estimated Values | 20 | 12% | Spiked |
Deleted Values | 1 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 161 | . | |
False Negatives | 0 | 0% | 0 out of 161 |
Not Spiked | 274 | . | |
False Positives | 0 | 0% | 0 out of 273 |
Plotted Points Statistics |
DIURON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 80% | 12% | 78% | 14% |
>= Reporting Level | 233 | 103% | 17% | 104% | 13% |
Total | 237 | 103% | 17% | 103% | 13% |
Sample Statistics |
DIURON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 237 | 100% | Spiked |
Estimated Values | 25 | 11% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 237 | . | |
False Negatives | 0 | 0% | 0 out of 237 |
Not Spiked | 198 | . | |
False Positives | 0 | 0% | 0 out of 198 |
Plotted Points Statistics |
FENURON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 7 | 100% | 39% | 116% | 45% |
>= Reporting Level | 157 | 102% | 20% | 104% | 14% |
Total | 164 | 102% | 21% | 104% | 15% |
Sample Statistics |
FENURON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 164 | 91% | Spiked |
Estimated Values | 82 | 46% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 6 | 3% | Spiked |
Spiked | 180 | . | |
False Negatives | 10 | 6% | 10 out of 180 |
Not Spiked | 255 | . | |
False Positives | 0 | 0% | 0 out of 255 |
Plotted Points Statistics |
FLUMETSULAM |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 5 | 129% | 21% | 125% | 19% |
>= Reporting Level | 153 | 145% | 61% | 130% | 50% |
Total | 158 | 145% | 60% | 130% | 49% |
Sample Statistics |
FLUMETSULAM |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 158 | 96% | Spiked |
Estimated Values | 122 | 74% | Spiked |
Deleted Values | 3 | 1% | Spiked + Not Spiked |
Spiked, Censored | 2 | 1% | Spiked |
Spiked | 164 | . | |
False Negatives | 4 | 2% | 4 out of 164 |
Not Spiked | 271 | . | |
False Positives | 9 | 3% | 9 out of 268 |
Plotted Points Statistics |
FLUOMETURON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 9 | 110% | 20% | 110% | 18% |
>= Reporting Level | 251 | 100% | 15% | 100% | 12% |
Total | 260 | 100% | 15% | 101% | 12% |
Sample Statistics |
FLUOMETURON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 260 | 100% | Spiked |
Estimated Values | 28 | 11% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 261 | . | |
False Negatives | 1 | 0% | 1 out of 261 |
Not Spiked | 174 | . | |
False Positives | 0 | 0% | 0 out of 174 |
Plotted Points Statistics |
IMAZAQUIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 10 | 208% | 78% | 181% | 47% |
>= Reporting Level | 219 | 164% | 64% | 146% | 55% |
Total | 229 | 166% | 65% | 150% | 53% |
Sample Statistics |
IMAZAQUIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 229 | 100% | Spiked |
Estimated Values | 229 | 100% | Spiked |
Deleted Values | 4 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 232 | . | |
False Negatives | 0 | 0% | 0 out of 229 |
Not Spiked | 203 | . | |
False Positives | 0 | 0% | 0 out of 202 |
Plotted Points Statistics |
IMAZETHAPYR |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 11 | 156% | 49% | 136% | 44% |
>= Reporting Level | 159 | 134% | 42% | 127% | 41% |
Total | 170 | 135% | 42% | 128% | 40% |
Sample Statistics |
IMAZETHAPYR |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 170 | 99% | Spiked |
Estimated Values | 95 | 55% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 1% | Spiked |
Spiked | 172 | . | |
False Negatives | 1 | 1% | 1 out of 172 |
Not Spiked | 263 | . | |
False Positives | 2 | 1% | 2 out of 263 |
Plotted Points Statistics |
IMIDACLOPRID |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 8 | 109% | 24% | 112% | 29% |
>= Reporting Level | 207 | 133% | 42% | 124% | 33% |
Total | 215 | 132% | 42% | 123% | 32% |
Sample Statistics |
IMIDACLOPRID |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 215 | 99% | Spiked |
Estimated Values | 73 | 33% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 218 | . | |
False Negatives | 3 | 1% | 3 out of 218 |
Not Spiked | 217 | . | |
False Positives | 0 | 0% | 0 out of 217 |
Plotted Points Statistics |
LINURON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 181 | 98% | 15% | 99% | 11% |
Total | 181 | 98% | 15% | 99% | 11% |
Sample Statistics |
LINURON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 181 | 100% | Spiked |
Estimated Values | 14 | 8% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 181 | . | |
False Negatives | 0 | 0% | 0 out of 181 |
Not Spiked | 254 | . | |
False Positives | 1 | 0% | 1 out of 254 |
Plotted Points Statistics |
MCPA |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 14 | 89% | 27% | 82% | 33% |
>= Reporting Level | 227 | 86% | 23% | 82% | 19% |
Total | 241 | 86% | 23% | 82% | 19% |
Sample Statistics |
MCPA |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 241 | 97% | Spiked |
Estimated Values | 51 | 21% | Spiked |
Deleted Values | 4 | 1% | Spiked + Not Spiked |
Spiked, Censored | 6 | 2% | Spiked |
Spiked | 250 | . | |
False Negatives | 1 | 0% | 1 out of 248 |
Not Spiked | 185 | . | |
False Positives | 1 | 1% | 1 out of 183 |
Plotted Points Statistics |
MCPB |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 29 | 65% | 18% | 64% | 11% |
>= Reporting Level | 118 | 71% | 23% | 66% | 18% |
Total | 147 | 69% | 22% | 65% | 16% |
Sample Statistics |
MCPB |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 147 | 83% | Spiked |
Estimated Values | 87 | 49% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 9 | 5% | Spiked |
Spiked | 178 | . | |
False Negatives | 22 | 12% | 22 out of 178 |
Not Spiked | 257 | . | |
False Positives | 0 | 0% | 0 out of 257 |
Plotted Points Statistics |
METALAXYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 100% | 6% | 100% | 6% |
>= Reporting Level | 217 | 96% | 14% | 98% | 11% |
Total | 219 | 96% | 14% | 98% | 11% |
Sample Statistics |
METALAXYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 219 | 99% | Spiked |
Estimated Values | 21 | 10% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 221 | . | |
False Negatives | 2 | 1% | 2 out of 221 |
Not Spiked | 214 | . | |
False Positives | 1 | 0% | 1 out of 214 |
Plotted Points Statistics |
METHIOCARB |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 3 | 88% | 3% | 89% | 4% |
>= Reporting Level | 161 | 79% | 31% | 88% | 23% |
Total | 164 | 79% | 30% | 88% | 23% |
Sample Statistics |
METHIOCARB |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 164 | 91% | Spiked |
Estimated Values | 47 | 26% | Spiked |
Deleted Values | 3 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 1% | Spiked |
Spiked | 181 | . | |
False Negatives | 15 | 8% | 15 out of 180 |
Not Spiked | 254 | . | |
False Positives | 0 | 0% | 0 out of 252 |
Plotted Points Statistics |
METHOMYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 8 | 107% | 13% | 103% | 14% |
>= Reporting Level | 180 | 91% | 30% | 100% | 20% |
Total | 188 | 92% | 30% | 100% | 20% |
Sample Statistics |
METHOMYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 188 | 97% | Spiked |
Estimated Values | 154 | 79% | Spiked |
Deleted Values | 6 | 1% | Spiked + Not Spiked |
Spiked, Censored | 1 | 1% | Spiked |
Spiked | 196 | . | |
False Negatives | 5 | 3% | 5 out of 194 |
Not Spiked | 239 | . | |
False Positives | 0 | 0% | 0 out of 235 |
Plotted Points Statistics |
METHOMYL OXIME |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 2 | 13% | 12% | 13% | 13% |
Total | 2 | 13% | 12% | 13% | 13% |
Sample Statistics |
METHOMYL OXIME |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 2 | 33% | Spiked |
Estimated Values | 2 | 33% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 6 | . | |
False Negatives | 4 | 67% | 4 out of 6 |
Not Spiked | 13 | . | |
False Positives | 0 | 0% | 0 out of 13 |
Plotted Points Statistics |
METSULFURON METHYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 11 | 95% | 25% | 94% | 33% |
>= Reporting Level | 148 | 63% | 39% | 64% | 33% |
Total | 159 | 65% | 39% | 65% | 36% |
Sample Statistics |
METSULFURON METHYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 159 | 89% | Spiked |
Estimated Values | 159 | 89% | Spiked |
Deleted Values | 5 | 1% | Spiked + Not Spiked |
Spiked, Censored | 4 | 2% | Spiked |
Spiked | 181 | . | |
False Negatives | 15 | 8% | 15 out of 178 |
Not Spiked | 254 | . | |
False Positives | 1 | 0% | 1 out of 252 |
Plotted Points Statistics |
NEBURON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 186 | 94% | 15% | 93% | 14% |
Total | 186 | 94% | 15% | 93% | 14% |
Sample Statistics |
NEBURON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 186 | 100% | Spiked |
Estimated Values | 14 | 8% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 186 | . | |
False Negatives | 0 | 0% | 0 out of 186 |
Not Spiked | 249 | . | |
False Positives | 0 | 0% | 0 out of 249 |
Plotted Points Statistics |
NICOSULFURON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 9 | 77% | 30% | 84% | 14% |
>= Reporting Level | 137 | 215% | 316% | 122% | 95% |
Total | 146 | 206% | 308% | 112% | 91% |
Sample Statistics |
NICOSULFURON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 146 | 90% | Spiked |
Estimated Values | 132 | 81% | Spiked |
Deleted Values | 4 | 1% | Spiked + Not Spiked |
Spiked, Censored | 3 | 2% | Spiked |
Spiked | 167 | . | |
False Negatives | 14 | 9% | 14 out of 163 |
Not Spiked | 268 | . | |
False Positives | 0 | 0% | 0 out of 268 |
Plotted Points Statistics |
NORFLURAZON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 225 | 98% | 23% | 102% | 16% |
Total | 225 | 98% | 23% | 102% | 16% |
Sample Statistics |
NORFLURAZON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 225 | 99% | Spiked |
Estimated Values | 95 | 42% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 0% | Spiked |
Spiked | 227 | . | |
False Negatives | 1 | 0% | 1 out of 227 |
Not Spiked | 208 | . | |
False Positives | 0 | 0% | 0 out of 208 |
Plotted Points Statistics |
ORYZALIN |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 6 | 75% | 9% | 77% | 12% |
>= Reporting Level | 176 | 80% | 18% | 79% | 17% |
Total | 182 | 80% | 17% | 79% | 17% |
Sample Statistics |
ORYZALIN |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 182 | 96% | Spiked |
Estimated Values | 19 | 10% | Spiked |
Deleted Values | 1 | 0% | Spiked + Not Spiked |
Spiked, Censored | 5 | 3% | Spiked |
Spiked | 190 | . | |
False Negatives | 3 | 2% | 3 out of 190 |
Not Spiked | 245 | . | |
False Positives | 2 | 1% | 2 out of 244 |
Plotted Points Statistics |
OXAMYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 7 | 86% | 38% | 95% | 22% |
>= Reporting Level | 167 | 92% | 42% | 97% | 25% |
Total | 174 | 92% | 41% | 97% | 25% |
Sample Statistics |
OXAMYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 174 | 90% | Spiked |
Estimated Values | 108 | 56% | Spiked |
Deleted Values | 6 | 1% | Spiked + Not Spiked |
Spiked, Censored | 6 | 3% | Spiked |
Spiked | 196 | . | |
False Negatives | 13 | 7% | 13 out of 193 |
Not Spiked | 239 | . | |
False Positives | 2 | 1% | 2 out of 236 |
Plotted Points Statistics |
OXAMYL OXIME |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 4 | 32% | 15% | 29% | 13% |
Total | 4 | 32% | 15% | 29% | 13% |
Sample Statistics |
OXAMYL OXIME |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 4 | 67% | Spiked |
Estimated Values | 4 | 67% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 6 | . | |
False Negatives | 2 | 33% | 2 out of 6 |
Not Spiked | 13 | . | |
False Positives | 1 | 8% | 1 out of 13 |
Plotted Points Statistics |
PICLORAM |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 104% | 51% | 104% | 53% |
>= Reporting Level | 185 | 83% | 43% | 79% | 28% |
Total | 187 | 83% | 43% | 79% | 28% |
Sample Statistics |
PICLORAM |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 187 | 94% | Spiked |
Estimated Values | 80 | 40% | Spiked |
Deleted Values | 3 | 1% | Spiked + Not Spiked |
Spiked, Censored | 4 | 2% | Spiked |
Spiked | 201 | . | |
False Negatives | 9 | 5% | 9 out of 200 |
Not Spiked | 234 | . | |
False Positives | 2 | 1% | 2 out of 232 |
Plotted Points Statistics |
PROPHAM |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 6 | 105% | 24% | 100% | 21% |
>= Reporting Level | 163 | 94% | 15% | 94% | 13% |
Total | 169 | 94% | 16% | 94% | 14% |
Sample Statistics |
PROPHAM |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 169 | 98% | Spiked |
Estimated Values | 16 | 9% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 2 | 1% | Spiked |
Spiked | 173 | . | |
False Negatives | 2 | 1% | 2 out of 173 |
Not Spiked | 262 | . | |
False Positives | 0 | 0% | 0 out of 262 |
Plotted Points Statistics |
PROPICONAZOLE (TILT) |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 4 | 82% | 18% | 79% | 19% |
>= Reporting Level | 197 | 93% | 25% | 93% | 17% |
Total | 201 | 93% | 24% | 93% | 18% |
Sample Statistics |
PROPICONAZOLE (TILT) |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 201 | 99% | Spiked |
Estimated Values | 22 | 11% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 0% | Spiked |
Spiked | 203 | . | |
False Negatives | 1 | 0% | 1 out of 203 |
Not Spiked | 232 | . | |
False Positives | 0 | 0% | 0 out of 232 |
Plotted Points Statistics |
PROPOXUR |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
>= Reporting Level | 183 | 100% | 20% | 102% | 18% |
Total | 183 | 100% | 20% | 102% | 18% |
Sample Statistics |
PROPOXUR |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 183 | 99% | Spiked |
Estimated Values | 38 | 21% | Spiked |
Deleted Values | 3 | 1% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 185 | . | |
False Negatives | 1 | 1% | 1 out of 184 |
Not Spiked | 250 | . | |
False Positives | 0 | 0% | 0 out of 248 |
Plotted Points Statistics |
SIDURON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 3 | 94% | 6% | 90% | 9% |
>= Reporting Level | 211 | 104% | 24% | 107% | 18% |
Total | 214 | 104% | 24% | 106% | 18% |
Sample Statistics |
SIDURON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 214 | 100% | Spiked |
Estimated Values | 19 | 9% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 0% | Spiked |
Spiked | 215 | . | |
False Negatives | 0 | 0% | 0 out of 215 |
Not Spiked | 220 | . | |
False Positives | 0 | 0% | 0 out of 220 |
Plotted Points Statistics |
SULFOMETURON METHYL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 8 | 96% | 44% | 114% | 63% |
>= Reporting Level | 172 | 106% | 51% | 97% | 51% |
Total | 180 | 105% | 51% | 98% | 52% |
Sample Statistics |
SULFOMETURON METHYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 180 | 98% | Spiked |
Estimated Values | 85 | 46% | Spiked |
Deleted Values | 1 | 0% | Spiked + Not Spiked |
Spiked, Censored | 3 | 2% | Spiked |
Spiked | 183 | . | |
False Negatives | 0 | 0% | 0 out of 183 |
Not Spiked | 212 | . | |
False Positives | 0 | 0% | 0 out of 211 |
Plotted Points Statistics |
TEBUTHIURON |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 2 | 137% | 7% | 137% | 7% |
>= Reporting Level | 228 | 124% | 23% | 122% | 23% |
Total | 230 | 124% | 23% | 122% | 23% |
Sample Statistics |
TEBUTHIURON |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 230 | 100% | Spiked |
Estimated Values | 16 | 7% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 230 | . | |
False Negatives | 0 | 0% | 0 out of 230 |
Not Spiked | 205 | . | |
False Positives | 0 | 0% | 0 out of 205 |
Plotted Points Statistics |
TERBACIL |
Spike Level | N | Mean | Std-Dev. | Median | F_Pseudo |
---|---|---|---|---|---|
< Reporting Level | 3 | 121% | 5% | 122% | 7% |
>= Reporting Level | 181 | 102% | 32% | 107% | 19% |
Total | 184 | 103% | 32% | 108% | 20% |
Sample Statistics |
TERBACIL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 184 | 97% | Spiked |
Estimated Values | 66 | 35% | Spiked |
Deleted Values | 0 | 0% | Spiked + Not Spiked |
Spiked, Censored | 1 | 1% | Spiked |
Spiked | 189 | . | |
False Negatives | 4 | 2% | 4 out of 189 |
Not Spiked | 246 | . | |
False Positives | 1 | 0% | 1 out of 246 |
Sample Statistics |
TRIBENURON-METHYL |
Characteristic | N | % | % Basis |
---|---|---|---|
Plotted | 0 | 0% | Spiked |
Estimated Values | 0 | 0% | Spiked |
Deleted Values | 117 | 84% | Spiked + Not Spiked |
Spiked, Censored | 0 | 0% | Spiked |
Spiked | 32 | . | |
False Negatives | 6 | 100% | 6 out of 6 |
Not Spiked | 107 | . | |
False Positives | 0 | 0% | 0 out of 16 |